Space Research Advances on 3 Continents

WASHINGTON—Experimenters starved for spaceflight opportunities may find all the lab space they need in Earth orbit if a small Colorado company is able to turn the space shuttle's giant external fuel tanks into privately owned orbiting science facilities. Next week a group of 40 scientists, government officials and engineers will attend a closed workshop in Boulder to take a first crack at defining science requirements for the "Labitat," as the External Tank Company (ETCO) has labeled its p

Written byTony Reichhardt
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Next week a group of 40 scientists, government officials and engineers will attend a closed workshop in Boulder to take a first crack at defining science requirements for the "Labitat," as the External Tank Company (ETCO) has labeled its proposed facility. The meeting is sponsored by the University Corporation for Atmospheric Research (UCAR)—a consortium of 55 universities that owns 80 percent of ETCO's stock—NASA and several other cosponsors, including Martin Marietta, which builds the shuttle fuel tanks.

Although the idea of salvaging the tanks was first proposed many years ago, NASA had never expressed any particular interest in pursuing it—in part because no one had shown any clear use for a tank, stranded 125 miles above the Earth, that would quickly become a dangerous piece of space junk unless its orbit were raised and stabilized. Currently, the tank reaches 98 percent of orbital velocity before being dropped to burn up ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies